Commentary: Antibiotic Resistance, Sustainable Development 2030 and Poverty in Developing Countries
DOI:
https://doi.org/10.47604/jdcs.2264Keywords:
Sustainable Development - 2030, Antibiotic Resistance, PovertyAbstract
Sustainable Development - 2030 is poised for a transformative global landscape, marked by two pressing challenges: antibiotic resistance, an escalating public health crisis, and the pursuit of Sustainable Development Goals (SDGs) to alleviate poverty and enhance living standards. This commentary explores the intricate relationship between antibiotic resistance, the 2030 agenda for sustainable development, and poverty in developing countries. Antibiotic resistance, primarily fuelled by overuse and misuse, threatens to intensify the burden of infectious diseases, particularly among vulnerable populations. Concurrently, sustainable development in these regions is beset with hurdles. Eradicating poverty, a central SDG-2030 goal hinges on addressing healthcare disparities and the impacts of antibiotic resistance. This in-depth analysis comprehensively examines the complex interplay of these factors, evaluating the challenges they pose to the SDGs-2030. It assesses the current state of sustainable development and its potential to uplift impoverished communities, highlighting the consequences of antibiotic resistance on healthcare access and the challenges related to achieving food security amid antibiotic residues. The paper explores strategies and obstacles in the dual pursuit of poverty elimination and antibiotic resistance mitigation, emphasizing the need for holistic, evidence-based solutions across social, economic, environmental, and health dimensions. These commentaries offer insights and recommendations to inspire proactive efforts towards a more equitable and sustainable future.
Downloads
References
World Health Organization. Global antimicrobial resistance and use surveillance system (GLASS) report: 2021.
World Health Organization. Health in 2015: from MDGs, millennium development goals to SDGs, sustainable development goals.
Ledingham K, Hinchliffe S, Jackson M, Thomas F, Tomson G. Antibiotic resistance: using a cultural contexts of health approach to address a global health challenge.
Simmons B. Improving access to essential medicines: 2021.
World Health Organization. World Health Statistics 2016 [OP]: Monitoring Health for the Sustainable Development Goals (SDGs). World Health Organization; 2016 Jun 8. P.7.
Sakeena MH, Bennett AA, McLachlan AJ. Non-prescription sales of antimicrobial agents at community pharmacies in developing countries: a systematic review. International journal of antimicrobial agents. 2018 Dec 1;52(6):771-82.
World Health Organization. Antimicrobial resistance and primary health care. World Health Organization; 2018.
Nair M, Zeegers MP, Varghese GM, Burza S. India's National Action Plan on Antimicrobial Resistance: a critical perspective. Journal of Global Antimicrobial Resistance. 2021 Dec 1;27:236-8.
Manyi-Loh C, Mamphweli S, Meyer E, Okoh A. Antibiotic use in agriculture and its consequential resistance in environmental sources: potential public health implications. Molecules. 2018 Mar 30;23(4):795.
Lim, Michelle ML, Peter Søgaard Jørgensen, and Carina A. Wyborn. "Reframing the sustainable development goals to achieve sustainable development in the Anthropocene"”a systems approach." Ecology and Society 23.3. 2018.
Roope LS, Smith RD, Pouwels KB, Buchanan J, Abel L, Eibich P, Butler CC, Tan PS, Walker AS, Robotham JV, Wordsworth S. The challenge of antimicrobial resistance: what economics can contribute. Science. 2019 Apr 5;364(6435):eaau4679.
Enyiukwu DN, Nwaogu GA, Bassey IN, Maranzu JO, Chukwu LA. Imperativeness of Agricultural Technology for Sustainable Crop Production, Food Security and Public Health in Sub-Saharan Africa.
Akinyemi AO. Exploring integrated pest management strategies in the control of the fall armyworm in smallholder organic agriculture farms in Africa. Agro-Science. 2021 Sep 29;20(3):65-70.
Darwish WS, Eldaly EA, El-Abbasy MT, Ikenaka Y, Nakayama S, Ishizuka M. Antibiotic residues in food: the African scenario. Japanese Journal of Veterinary Research. 2013 Feb;61(Supplement):S13-22.
Greco S, Putans R, Springe L. Antimicrobial and antibiotic resistance in developing countries: Health economics, global governance, and sustainable development goals. In Antimicrobial Resistance 2022 Aug 3 (pp. 113-140). CRC Press.
Godman B, Egwuenu A, Haque M, Malande OO, Schellack N, Kumar S, Saleem Z, Sneddon J, Hoxha I, Islam S, Mwita J. Strategies to improve antimicrobial utilization with a special focus on developing countries. Life. 2021 Jun 7;11(6):528.
Godman B, Egwuenu A, Haque M, Malande OO, Schellack N, Kumar S, Saleem Z, Sneddon J, Hoxha I, Islam S, Mwita J. Strategies to improve antimicrobial utilization with a special focus on developing countries. Life. 2021 Jun 7;11(6):528.
Bhattacharya Chakravarty A, Rangan S, Dholakia Y, Rai S, Kamble S, Raste T, Shah S, Shah S, Mistry N. Such a long journey: What health seeking pathways of patients with drug resistant tuberculosis in Mumbai tell us. PloS one. 2019 Jan 17;14(1):e0209924.
Nicholson T, Admay C, Shakow A, Keshavjee S. Double standards in global health: medicine, human rights law and multidrug-resistant TB treatment policy. Health and human rights. 2016 Jun;18(1):85.
Ancillotti M, Eriksson S, Veldwijk J, Nihln Fahlquist J, Andersson DI, Godskesen T. Public awareness and individual responsibility needed for judicious use of antibiotics: a qualitative study of public beliefs and perceptions. BMC Public Health. 2018 Dec;18:1-9.
Dadgostar P. Antimicrobial resistance: implications and costs. Infection and drug resistance. 2019 Dec 20:3903-10.
Rushton J, Gilbert W, Coyne LA, Thomas LF, Pinchbeck G, Williams N. Interactions between intensifying livestock production for food and nutrition security, and increased vulnerability to AMR and zoonoses. InScience Forum 2018 Background Paper 2018 Aug 15. CGIAR Independent Science and Partnership Council.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Jawad M. A.
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution (CC-BY) 4.0 License that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
